Cell Point CEO and leadership

Jerry Bryant, Jr., is a founding member of Cell>Point, the CTO and has been providing financial support to the company since its beginning. Mr. Bryant is also President and Managing Member of Vyripharm Biopharmaceuticals, a majority owned subsidiary of Cell>Point. Mr. Bryant brings 15 years in research experience in molecular biology, imaging and oncology. Prior to the establishment of Cell>Point, Mr. Bryant worked as a research assistant from 1994 through 1999 in the Department of Medicine, Division of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center. During 1999 and 2000, Mr. Bryant served as President of Allcure JEMA, Inc. Mr. Bryant received his B.S. from Tennessee State University in 1987 and M.S. from the University of Florida in 1991.

Jerry Bryant, Jr., is a founding member of Cell>Point, the CTO and has been providing financial support to the company since its beginning. Mr. Bryant is also President and Managing Member of Vyripharm Biopharmaceuticals, a majority owned subsidiary of Cell>Point. Mr. Bryant brings 15 years in research experience in molecular biology, imaging and oncology. Prior to the establishment of Cell>Point, Mr. Bryant worked as a research assistant from 1994 through 1999 in the Department of Medicine, Division of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center. During 1999 and 2000, Mr. Bryant served as President of Allcure JEMA, Inc. Mr. Bryant received his B.S. from Tennessee State University in 1987 and M.S. from the University of Florida in 1991.